Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma

Tsutomu Masaki, Masaaki Tokuda, Makoto Ohnishi, Seishiro Watanabe, Takashi Fujimura, Kazuhiro Miyamoto, Toshifumi Itano, Hideki Matsui, Keiji Arima, Mutsunori Shirai, Takashi Maeba, Kenichi Sogawa, Ryoji Konishi, Kiyohide Taniguchi, Yoshio Hatanaka, Osamu Hatase, Mikio Nishioka

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Annexin (AX) constitutes a new family of Ca2+-dependent membrane- binding proteins; 13 of them have been described. Among these, annexin-I (AX- I) has displayed many biological functions in vitro. Its actual role in vivo, however, remains unknown. We already reported that AX-I was expressed in proliferating (regenerating) hepatocytes at both protein and messenger RNA (mRNA) levels. The role of AX-I in human hepatocellular carcinoma (HCC) remains obscure. In this study, the amounts of AX-I at protein and mRNA levels, as well as its localization, have been determined in the normal human liver, chronic hepatitis liver, and nontumorous and tumorous portions of HCC. AX-I was rarely found in normal and chronic liver tissues, whereas it is overexpressed at both the transcriptional and translational levels in tumorous and nontumorous regions of HCC. In addition, more AX-I was expressed in the tumorous portion than the nontumorous portion of HCC. AX-I was present in the hepatocytes and HCC cells, localized mainly in the cytoplasm. AX-I was overexpressed in poorly differentiated cancer cells. Furthermore, AX-I was tyrosine-phosphorylated in HCC. We also found that some of the AX-I-positive hepatocytes in the nontumorous tissues were derived from a particular subset of parenchymal cells (stem or oval cells). These results indicate that AX-I plays an important role in the malignant transformation process leading to HCC and that it is closely related to the histological grade of HCC. HCC would offer a novel tool with which to study the function of AX-I in malignant transformation.

Original languageEnglish
Pages (from-to)72-81
Number of pages10
JournalHepatology
Volume24
Issue number1
DOIs
Publication statusPublished - Jul 1996
Externally publishedYes

Fingerprint

Annexin A1
Protein Kinases
Hepatocellular Carcinoma
Hepatocytes
Liver
Annexins
Messenger RNA
Chronic Hepatitis
Tyrosine

ASJC Scopus subject areas

  • Hepatology

Cite this

Masaki, T., Tokuda, M., Ohnishi, M., Watanabe, S., Fujimura, T., Miyamoto, K., ... Nishioka, M. (1996). Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma. Hepatology, 24(1), 72-81. https://doi.org/10.1053/jhep.1996.v24.pm0008707286

Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma. / Masaki, Tsutomu; Tokuda, Masaaki; Ohnishi, Makoto; Watanabe, Seishiro; Fujimura, Takashi; Miyamoto, Kazuhiro; Itano, Toshifumi; Matsui, Hideki; Arima, Keiji; Shirai, Mutsunori; Maeba, Takashi; Sogawa, Kenichi; Konishi, Ryoji; Taniguchi, Kiyohide; Hatanaka, Yoshio; Hatase, Osamu; Nishioka, Mikio.

In: Hepatology, Vol. 24, No. 1, 07.1996, p. 72-81.

Research output: Contribution to journalArticle

Masaki, T, Tokuda, M, Ohnishi, M, Watanabe, S, Fujimura, T, Miyamoto, K, Itano, T, Matsui, H, Arima, K, Shirai, M, Maeba, T, Sogawa, K, Konishi, R, Taniguchi, K, Hatanaka, Y, Hatase, O & Nishioka, M 1996, 'Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma', Hepatology, vol. 24, no. 1, pp. 72-81. https://doi.org/10.1053/jhep.1996.v24.pm0008707286
Masaki, Tsutomu ; Tokuda, Masaaki ; Ohnishi, Makoto ; Watanabe, Seishiro ; Fujimura, Takashi ; Miyamoto, Kazuhiro ; Itano, Toshifumi ; Matsui, Hideki ; Arima, Keiji ; Shirai, Mutsunori ; Maeba, Takashi ; Sogawa, Kenichi ; Konishi, Ryoji ; Taniguchi, Kiyohide ; Hatanaka, Yoshio ; Hatase, Osamu ; Nishioka, Mikio. / Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma. In: Hepatology. 1996 ; Vol. 24, No. 1. pp. 72-81.
@article{e23335153e0a416abeb3505fef22755e,
title = "Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma",
abstract = "Annexin (AX) constitutes a new family of Ca2+-dependent membrane- binding proteins; 13 of them have been described. Among these, annexin-I (AX- I) has displayed many biological functions in vitro. Its actual role in vivo, however, remains unknown. We already reported that AX-I was expressed in proliferating (regenerating) hepatocytes at both protein and messenger RNA (mRNA) levels. The role of AX-I in human hepatocellular carcinoma (HCC) remains obscure. In this study, the amounts of AX-I at protein and mRNA levels, as well as its localization, have been determined in the normal human liver, chronic hepatitis liver, and nontumorous and tumorous portions of HCC. AX-I was rarely found in normal and chronic liver tissues, whereas it is overexpressed at both the transcriptional and translational levels in tumorous and nontumorous regions of HCC. In addition, more AX-I was expressed in the tumorous portion than the nontumorous portion of HCC. AX-I was present in the hepatocytes and HCC cells, localized mainly in the cytoplasm. AX-I was overexpressed in poorly differentiated cancer cells. Furthermore, AX-I was tyrosine-phosphorylated in HCC. We also found that some of the AX-I-positive hepatocytes in the nontumorous tissues were derived from a particular subset of parenchymal cells (stem or oval cells). These results indicate that AX-I plays an important role in the malignant transformation process leading to HCC and that it is closely related to the histological grade of HCC. HCC would offer a novel tool with which to study the function of AX-I in malignant transformation.",
author = "Tsutomu Masaki and Masaaki Tokuda and Makoto Ohnishi and Seishiro Watanabe and Takashi Fujimura and Kazuhiro Miyamoto and Toshifumi Itano and Hideki Matsui and Keiji Arima and Mutsunori Shirai and Takashi Maeba and Kenichi Sogawa and Ryoji Konishi and Kiyohide Taniguchi and Yoshio Hatanaka and Osamu Hatase and Mikio Nishioka",
year = "1996",
month = "7",
doi = "10.1053/jhep.1996.v24.pm0008707286",
language = "English",
volume = "24",
pages = "72--81",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Enhanced expression of the protein kinase substrate annexin I in human hepatocellular carcinoma

AU - Masaki, Tsutomu

AU - Tokuda, Masaaki

AU - Ohnishi, Makoto

AU - Watanabe, Seishiro

AU - Fujimura, Takashi

AU - Miyamoto, Kazuhiro

AU - Itano, Toshifumi

AU - Matsui, Hideki

AU - Arima, Keiji

AU - Shirai, Mutsunori

AU - Maeba, Takashi

AU - Sogawa, Kenichi

AU - Konishi, Ryoji

AU - Taniguchi, Kiyohide

AU - Hatanaka, Yoshio

AU - Hatase, Osamu

AU - Nishioka, Mikio

PY - 1996/7

Y1 - 1996/7

N2 - Annexin (AX) constitutes a new family of Ca2+-dependent membrane- binding proteins; 13 of them have been described. Among these, annexin-I (AX- I) has displayed many biological functions in vitro. Its actual role in vivo, however, remains unknown. We already reported that AX-I was expressed in proliferating (regenerating) hepatocytes at both protein and messenger RNA (mRNA) levels. The role of AX-I in human hepatocellular carcinoma (HCC) remains obscure. In this study, the amounts of AX-I at protein and mRNA levels, as well as its localization, have been determined in the normal human liver, chronic hepatitis liver, and nontumorous and tumorous portions of HCC. AX-I was rarely found in normal and chronic liver tissues, whereas it is overexpressed at both the transcriptional and translational levels in tumorous and nontumorous regions of HCC. In addition, more AX-I was expressed in the tumorous portion than the nontumorous portion of HCC. AX-I was present in the hepatocytes and HCC cells, localized mainly in the cytoplasm. AX-I was overexpressed in poorly differentiated cancer cells. Furthermore, AX-I was tyrosine-phosphorylated in HCC. We also found that some of the AX-I-positive hepatocytes in the nontumorous tissues were derived from a particular subset of parenchymal cells (stem or oval cells). These results indicate that AX-I plays an important role in the malignant transformation process leading to HCC and that it is closely related to the histological grade of HCC. HCC would offer a novel tool with which to study the function of AX-I in malignant transformation.

AB - Annexin (AX) constitutes a new family of Ca2+-dependent membrane- binding proteins; 13 of them have been described. Among these, annexin-I (AX- I) has displayed many biological functions in vitro. Its actual role in vivo, however, remains unknown. We already reported that AX-I was expressed in proliferating (regenerating) hepatocytes at both protein and messenger RNA (mRNA) levels. The role of AX-I in human hepatocellular carcinoma (HCC) remains obscure. In this study, the amounts of AX-I at protein and mRNA levels, as well as its localization, have been determined in the normal human liver, chronic hepatitis liver, and nontumorous and tumorous portions of HCC. AX-I was rarely found in normal and chronic liver tissues, whereas it is overexpressed at both the transcriptional and translational levels in tumorous and nontumorous regions of HCC. In addition, more AX-I was expressed in the tumorous portion than the nontumorous portion of HCC. AX-I was present in the hepatocytes and HCC cells, localized mainly in the cytoplasm. AX-I was overexpressed in poorly differentiated cancer cells. Furthermore, AX-I was tyrosine-phosphorylated in HCC. We also found that some of the AX-I-positive hepatocytes in the nontumorous tissues were derived from a particular subset of parenchymal cells (stem or oval cells). These results indicate that AX-I plays an important role in the malignant transformation process leading to HCC and that it is closely related to the histological grade of HCC. HCC would offer a novel tool with which to study the function of AX-I in malignant transformation.

UR - http://www.scopus.com/inward/record.url?scp=15844375461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15844375461&partnerID=8YFLogxK

U2 - 10.1053/jhep.1996.v24.pm0008707286

DO - 10.1053/jhep.1996.v24.pm0008707286

M3 - Article

VL - 24

SP - 72

EP - 81

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 1

ER -